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Abstract
Almost three decades ago, we presented a model where the extracellular matrix (ECM) was 
postulated to influence gene expression and tissue-specificity through the action of ECM 
receptors and the cytoskeleton.  This hypothesis implied that ECM molecules could signal to the 
nucleus and that the unit of function in higher organisms was not the cell alone, but the cell plus 
its microenvironment.  We now know that ECM invokes changes in tissue and organ 
architecture and that tissue, cell, nuclear and chromatin structure are changed profoundly as a 
result of and during malignant progression. Whereas some evidence has been generated for a link 
between ECM-induced alterations in tissue architecture and changes in both nuclear and 
chromatin organization, the manner by which these changes actively induce or repress gene 
expression in normal and malignant cells is a topic in need of further attention. Here, we will 
discuss some key findings that may provide insights into mechanisms through which ECM could 
influence gene transcription and how tumor cells acquire the ability to overcome these levels of 
control.  
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I. Introduction 
“No man is an island, entire of itself; every man is a piece of the continent, a part of the main.” 
John Donne (1573-1631) 
Over the years, studies of transcription, chromatin structure and nuclear organization, mostly 
performed in lower organisms or in cells isolated from higher organisms and cultivated on tissue 
culture plastic, have provided important and valuable evidence for elucidating intracellular 
signaling events important for gene expression. But much still remains to be elucidated in order 
to understand the intricate complexity of gene expression within a three-dimensional tissue 
context. Vertebrate cells exist as part of an integrated unit of multiple cell types, i.e. an organ, in 
a milieu rich in growth factors, hormones and an assortment of ECM molecules, the combination 
of which is organ-specific. Similarly, the nucleus within each cell is not an isolated vessel. It is 
connected to its external milieu and the ECM through a dynamic intracellular network that 
includes the nuclear matrix, the nuclear envelope and the cytoskeleton. In the past few decades, a 
number of studies have provided evidence that the physical and biochemical signals transmitted 
from the ECM to the nucleus are indeed dynamic and reciprocal (Bissell et al., 1982; Lelievre et 
al., 1998; Plachot and Lelievre, 2004; Roskelley et al., 1994; Zoubiane et al., 2004). More 
specifically, the nature of ECM receptors and their signaling, and the nature of the connections 
between these receptors and intracellular components, such as the cytoskeleton and its 
interacting proteins, promote changes in nuclear events which influence gene expression and 
initiate the production of specific signaling molecules that are fed back into the extracellular 
environment which, in turn, influences the cell and the nucleus (Bissell et al., 1982) (Figure 1). 
Understanding how signaling by the ECM and its receptors are integrated into messages that 
alter chromatin structure and nuclear function is essential for knowing how a normal cell 
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functions in the context of a tissue and an organ, and for identifying aberrations that lead to the 
development of diseases such as cancer. Here we will discuss the influence of ECM on cellular 
and nuclear functions, as well as chromatin structure, and relate these changes to alterations in 
transcriptional events essential for functional differentiation and transformation. 
II. The Extracellular Matrix 
There are two broad subtypes of ECM: interstitial/stromal ECM and basement membrane (BM) 
(Guo and Giancotti, 2004). The interstitial matrix surrounds cells in the connective tissue (Guo 
and Giancotti, 2004), while the BM is present at the basolateral surface of different cell types in 
many tissues (Kalluri, 2003). The BM is composed mainly of laminin, type IV collagen, 
entactin/nidogen, and proteoglycans such as heparin sulfate that are deposited by many different 
cell types (Kalluri, 2003).  
In order to fully appreciate how profoundly a cell and its nucleus are affected by the ECM, one 
must consider that the composition of the ECM is constantly influenced by physiological 
effectors such as growth factors, cytokines, and hormones, and, thus, is continuously changing 
throughout development, ageing, tissue repair and tumor progression (Guo and Giancotti, 2004; 
Labat-Robert, 2003; Mott and Werb, 2004). There are now multiple types of ECM receptors that 
have been identified including integrins, syndecans, glypicans  and dystroglycan (Guo and 
Giancotti, 2004; Rizki and Bissell, 2004; Weir and Muschler, 2003).  Different integrins are 
known to activate distinct signaling pathways but the same integrin receptor can stimulate 
multiple signaling pathways (DeMali et al., 2003; Guo and Giancotti, 2004).  
Exposure to ECM promotes changes in cell shape, initiates the clustering of neighboring integrin 
receptors at cell-matrix contact sites, and promotes the recruitment of kinases and adaptor 
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proteins that link these receptor molecules to the actin cytoskeleton (Schatzmann et al., 2003). 
These changes initiate a series of mechanical and biochemical signals within the cell that 
ultimately change the program of gene expression and influence cellular processes such as 
survival, transcription factor activation, and apoptosis (Schatzmann et al., 2003). In the case of 
mammary epithelial cells, changes in cell shape that are mediated by exposure to a laminin-rich 
ECM gel (lrECM) activate expression of the milk protein lactoferrin (Close et al., 1997; 
Roskelley et al., 1994) (Figure 2). When these cell shape changes are combined with further 
biochemical and mechanical signals generated from the prolactin receptor and laminin 1-induced 
activation of integrin receptors, the transcription of additional milk proteins such as β-casein is 
initiated, but the expression of growth factors such as TGF-β1 is inhibited concomitantly (Streuli 
et al., 1991; Streuli et al., 1995; Streuli et al., 1993). Following initial exposure to lrECM, 
morphogenic events take place that lead to the development of spherical, acinar structures with 
hollow lumen (Barcellos-Hoff et al., 1989). The formation of these structures is accompanied by 
growth arrest, enhancement of milk protein production, down-regulation of growth factors such 
as TGF-α, and the expression of new milk proteins such as whey acidic protein (WAP) 
(Barcellos-Hoff et al., 1989; Chen and Bissell, 1989; Lin et al., 1995; Petersen et al., 1992). As a 
result, the ability of lrECM to promote the functional differentiation of normal mammary 
epithelial cells into polar, acinar structures that produce and secrete milk requires several levels 
of control (Bissell et al., 1999; Lin and Bissell, 1993; Roskelley et al., 1995).  
III. ECM-Response DNA Elements 
One of the most convincing pieces of evidence linking the ECM to gene expression was the 
identification of an ECM response element in the promoter region of the bovine β-casein gene. 
Deletion analysis of the bovine β-casein promoter revealed that the transcriptional activation of 
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this promoter was completely dependent on a 160 bp BCE-1 transcriptional enhancer located 
approximately 1.5 kb upstream of the transcription start site (Schmidhauser et al., 1992). Since 
this discovery, ECM response elements have been identified in several other genes from different 
species (DiPersio et al., 1991; Novaro et al., 2004; Schmidhauser et al., 1994; Schmidhauser et 
al., 1992) (See Table 1). However, exactly how the ECM influences gene expression through 
these response elements is poorly understood.  
IV. Potential Mechanisms for the Transcriptional Activation of ECM-Response DNA 
Elements 
A). Exposure to ECM influences the nuclear translocation and DNA binding properties of 
specific transcription factors that bind to ECM-response elements. 
One mechanism through which exposure to ECM may influence the activation of response 
elements is by altering the levels of specific transcription factors residing in the nucleus.  
Cognate DNA binding elements for STAT5, and C/EBPβ reside in both the bovine β-casein and 
mouse ERα ECM-response elements (Myers et al., 1998; Novaro et al., 2004). Mutation analysis 
of these binding sites revealed that their requirement for activation of the β-casein promoter is 
absolute (Myers et al., 1998). In mammary epithelial cells, exposure to lrECM and prolactin 
promotes the phosphorylation and translocation of STAT5 into the nucleus (Edwards et al., 
1998; Gouilleux et al., 1994; Groner and Gouilleux, 1995; Ihle, 1996). Chromatin-binding 
proteins locate their cognate sites by scanning the 3D space of the nucleus and bind transiently to 
chromatin with a residence time on the order of seconds (Phair et al., 2004). An increase in 
STAT5 levels within the nucleus likely increases the frequency with which this factor interacts 
with its target DNA sites. In support of this, we have recently observed that exposure of mouse 
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mammary epithelial cells to lrECM and prolactin induces the recruitment of STAT5 to the β-
casein promoter (Xu et al., 2005). Whether lrECM treatment alters the nuclear levels of other 
factors important for β-casein expression such as C/EBPβ or GR remains to be determined. In a 
previous study, the culturing of primary rabbit mammary epithelial cells on collagen increased 
the expression levels of C/EBPβ  (Jolivet et al., 2001). In addition, we have also observed an 
increase in the binding of C/EBPβ to the endogenous mouse β-casein promoter in response to 
lrECM and prolactin treatment (Xu et al., 2005). Such evidence supports the possibility that 
lrECM affects gene transcription by influencing transcription factors levels within the nucleus.  
B). Exposure to ECM may initiate mechanical signals that alter the organization of nuclear 
factors in a manner that promotes activation of ECM-response elements  
However, the possibility remains that the expression level of some nuclear proteins does not 
change in response to ECM treatment. Exposure to ECM has profound effects on cell shape, and 
cytoskeletal organization (Roskelley et al., 1994; Zoubiane et al., 2004) and the integrity of the 
cytoskeleton is essential for both STAT5 nuclear translocation and β-casein transcription 
(Phung-Koskas et al., 2005; Roskelley et al., 1994; Zoubiane et al., 2004). Furthermore, the 
cytoskeleton bridges the nucleus with the ECM by interacting with both nuclear envelope 
proteins and integrin receptors on the plasma membrane (Crisp et al., 2006; D'Angelo and 
Hetzer, 2006; Fey et al., 1984a; Fey et al., 1984b; Janmey, 1998; Wilhelmsen et al., 2005). 
Lamins help constitute the nuclear envelope and organize DNA into loop domains (Davie, 1995). 
Alterations in the organization of cytoskeletal filaments, distortions in nuclear shape and a 
redistribution of nucleoli along an axis of applied tension have been observed in bovine capillary 
epithelial cells in response to the mechanical tug of an integrin receptor lining the cell surface 
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(Maniotis et al., 1997; Maniotis et al., 2005). Thus, it is possible that the ECM promotes 
transcriptional activation of response elements by changing cytoskeletal organization, which 
may, in turn, alter the arrangement of nuclear components to promote a localized concentration 
of transcription factors to areas of the nucleus containing target DNA sequences. In addition, 
exposure to ECM may also stimulate cellular events that post-translationally modify and, 
therefore, alter the properties of transcription factors and chromatin remodeling enzymes. 
C). ECM-induced activation of DNA response elements involves mechanisms that invoke 
changes in chromatin structure  
Regardless of whether the ECM mediates an increase in the nuclear levels of transcription factors 
and/or an increase in the proximity of these factors to their target DNA binding sites, the fact 
remains that exposure of mammary epithelial cells to lrECM induces STAT5 and C/EBPβ 
binding to DNA sites that are within close proximity of one another within the BCE-1 element 
and the mouse β-casein promoter (Myers et al., 1998; Rosen et al., 1999; Xu et al., 2005). We 
have shown previously that the treatment of stably transfected mouse mammary epithelial cells 
with a general histone deacetylase inhibitor increases BCE-1 activity, albeit not to the same 
extent as cells treated with inhibitor and lrECM together (Myers et al., 1998). In a recent study, 
we also observed an increase in the association of acetylated histones with the endogenous 
mouse β-casein promoter after lrECM and prolactin treatment (Xu et al., 2005). Further 
examination of the effects of lrECM on transcription factor recruitment revealed that exposure to 
lrECM induced also the binding of Brg1 (Xu et al., 2005), an ATPase subunit of the SWI/SNF 
chromatin remodeling complex (de la Serna et al., 2006). Over-expression of a dominant 
negative Brg1 isoform significantly decreased β-casein RNA levels (Xu et al., 2005). These 
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results indicate that lrECM-mediated induction of β-casein gene transcription requires both 
histone acetylation and ATP-dependent chromatin remodeling.  
STAT5, GR and C/EBPβ have been shown to interact with histone acetyltransferases (Lee et al., 
1985; Li et al., 2003; Litterst et al., 2003; Pfitzner et al., 1998) and the transactivation potential 
of GR depends on its ability to recruit the chromatin remodeling factor Brg1 to target genes 
(Nagaich et al., 2004; Trotter and Archer, 2004). We have observed by co-immunoprecipitation 
analyses that STAT5, C/EBPβ and GR are associated with the SWI/SNF complex in response to 
lrECM and prolactin treatment (Xu et al., 2005). In addition, this treatment promotes the binding 
of RNA polymerase II to the endogenous mouse β-casein promoter (Xu et al., 2005). Therefore, 
besides altering the nuclear localization and DNA binding properties of transcription factors, 
exposure to lrECM promotes transcription factor-mediated recruitment of chromatin remodeling 
factors to the bovine BCE-1 enhancer and the endogenous mouse β-casein promoter. A localized 
decondensation in chromatin structure would allow additional factors such as RNA polymerase 
II to access their target DNA sites and potentiate further rounds of transcription (Figure 3). Such 
events support a currently popular paradigm for transcriptional activation that describes the 
recruitment of specific transcription factors to their cognate DNA sequences and their subsequent 
recruitment of chromatin remodeling- and DNA-modifying enzymes followed by the general 
transcriptional machinery (Kosak and Groudine, 2004).  
Interestingly, mouse mammary epithelial cells transiently transfected with a construct containing 
the BCE-1 element positioned upstream of a minimal bovine β-casein promoter cloned adjacent 
to a CAT reporter gene did not display an increase in BCE-1 activity upon exposure to lrECM 
and prolactin, while cells stably transfected with the same construct displayed a significantly 
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large induction (Myers et al., 1998). The fact that BCE-1 required integration into the genome to 
become transcriptionally active suggests that the proximity of this sequence to its target 
transcription factors, chromatin remodeling factors and the basal transcriptional machinery likely 
plays an important role in its activation. Thus, to accurately depict the factors and events 
involved in ECM-mediated gene expression, we must consider how the ECM could influence the 
general organization of the nucleus. 
V. Potential Mechanisms Through Which ECM Influences the General Organization of 
Nuclear Factors & Overall Transcriptional Activity 
The nucleus has a 10 micron diameter and contains approximately two meters of DNA 
(Getzenberg et al., 1991; Hager et al., 2004; Misteli, 2005). In order for this vast amount of DNA 
to fit within the confines of the nuclear envelope, it must be assembled into chromatin that 
undergoes several orders of compaction resulting in a DNA-protein assembly that differentially 
impedes the access of transcription factors to their cognate sites.  Residing alongside chromatin 
is a large number of nuclear proteins involved in diverse nuclear processes such as transcription, 
RNA splicing and DNA repair. Add to this the presence of RNA and proteins required for 
maintaining structural integrity of the nucleus and it becomes clear that the nucleus is a very 
crowded organelle indeed.  
Past studies have shown that transcription factors are located in discrete bodies within the 
nucleus (Handwerger and Gall, 2006; Lamond and Spector, 2003; Zimber et al., 2004). A 
number of investigators have speculated that these bodies are either protein storage sites or 
centers for the recruitment of specific regulatory cofactors in response to extracellular and 
intracellular signals (Boisvert et al., 2000; Borden, 2002; Pearson and Pelicci, 2001). Factor 
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recruitment to nuclear bodies is important for events such as proliferation, senescence, and 
apoptosis. It is thus clear that understanding the factors that affect nuclear organization and the 
role of nuclear organization in gene expression is essential for understanding cell development 
and ECM-induced differentiation. 
A). Of Mouse and Women: Application to Human Breast Epithelial Cells 
The principles learned from the phenotypic and functional behavior of mouse mammary 
epithelial cells in 3D culture have been applied to human cells with an added advantage: the 3D 
assay provides a rapid and robust assay with which to distinguish between non-malignant and 
malignant breast cells (Bissell et al., 2005; Bissell et al., 1999; Petersen et al., 1992; Schmeichel 
and Bissell, 2003). To examine the principle of ECM signaling to the nucleus in human cells, we 
showed that culturing non-malignant HMT-3522 (S1) human mammary epithelial cells on 
lrECM gels induced acinar morphogenesis, and caused the nuclear mitotic apparatus (NuMA), 
and the serine/arginine repeat-related nuclear matrix protein of 160 kDa (SRm160), to coalesce 
into discrete foci (Knowles et al., 2006; Lelievre et al., 1998). SRm160 is a splicing factor found 
in interchromatin granule clusters (IGCs). IGCs are considered to be storage sites for splicing 
factors (Huang et al., 1994; Misteli et al., 1997; Spector, 1993). Importantly, disturbing the 
integrity of NuMA foci with an antibody to its C-terminal end reversed lrECM-mediated changes 
in chromatin organization, disrupted the BM integrity and activated one or more matrix 
metalloproteinases (MMPs). Treatment of cells on lrECM with trichostatin A, a histone 
deacetylase inhibitor, also resulted in the disruption of NuMA foci, and the loss of BM. Plachot 
and Lelievre (2004) subsequently showed that treatment of acini formed by S1-HMT3522 cells 
with 5-aza-2’deoxycytidine, an inhibitor of DNA methylation, induced DNA hypomethylation 
and prevented the establishment of apical polarity (Plachot and Lelievre, 2004). These results 
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lend further credence to the concept of a dynamically reciprocal interaction between the nucleus 
and the ECM, and show that DNA organization, nuclear matrix organization and the BM are all 
intimately connected. While the principles appear to hold true, the exact events through which 
ECM influences nuclear and chromatin organization remain to be resolved.  
B). ECM-induced differentiation may involve the selective activation of particular tissue-
specific genes, but an overall decrease in gene activity 
Exposure of mouse mammary epithelial cells to lrECM decreased total levels of acetylated 
histones (Pujuguet et al., 2001) and the assembly of human mammary epithelial cells into 
functionally differentiated acinar structures on lrECM (Barcellos-Hoff et al., 1989; Petersen et 
al., 1992) is accompanied by a decrease in overall acetylated H4 levels, an increase in HP1γ , and 
an increase in the expression levels of MeCP2 (Plachot and Lelievre, 2004). Because these and 
the other results cited in the previous subsection promote and/or are a consequence of gene 
silencing, the findings suggest strongly that lrECM-induced differentiation of human mammary 
epithelial cells may involve changes in chromatin structure that are conducive to selective 
activation of particular tissue-specific genes, but an overall decrease in gene activity.  
Exposure to lrECM promotes cell cycle arrest (Fournier et al., 2006; Petersen et al., 1992) and 
this effect may play an important role in its ability to decrease overall transcriptional activity. For 
instance, in the nuclei of cells in G0/G1, the retinoblastoma (Rb) protein is complexed with c-
abl, a nonreceptor tyrosine kinase (Welch and Wang, 1993; Welch and Wang, 1995). When 
associated with Rb, nuclear c-abl is inactive; in cycling cells, however, cyclin-dependent kinases 
phosphorylate Rb and disrupt this complex, causing activation of nuclear c-abl which, in turn, 
activates RNA polymerase II by phosphorylating its C-terminal repeated domain (Baskaran et 
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al., 1996; Baskaran et al., 1993). In a recent study, the number of active RNA polymerase II 
molecules and the number of active transcription sites significantly decreased in mouse F9 
teratocarcinoma and totipotent mouse embryonic stem cells when they were induced to 
differentiate (Faro-Trindade and Cook, 2006). Thus, exposure to lrECM may decrease total 
levels of transcriptional activity by indirectly decreasing RNA polymerase II activity.  
A decrease in the number of transcription sites would eliminate the need for certain transcription 
factors and create a temporary surplus of these factors that could be redistributed to discrete 
nuclear domains such as promyelocytic leukemia (PML) nuclear bodies for storage and/or 
eventual degradation (Borden, 2002; Kosak and Groudine, 2004; Zimber et al., 2004). In support 
of this possibility, increasing the levels of a particular transcription factor by transient or stable 
expression causes excess factors to localize into PML bodies (Tsukamoto et al., 2000).   
A decrease in demand for transcription factors may also reduce the need for splicing factors. The 
C-terminal tail of the largest subunit of RNA polymerase II recruits splicing factors from nearby 
IGCs during transcription (Misteli and Spector, 1999). Treatment with α-amanitin, a specific 
inhibitor of RNA polyermase II (Lindell et al., 1970), causes these clusters to round up and 
prevents the movement of splicing factors from IGCs (Misteli et al., 1997). Thus, a decrease in 
overall transcription levels resulting from exposure to lrECM could be responsible for the 
formation of SRm160 foci we observed in mammary epithelial cells (Lelievre et al., 1998). In 
support of this, hnRNP RNA processing proteins were shown to accumulate into HERDS, 
heterogeneous clusters, within the interchromatin space in response to transcriptional arrest 
(Biggiogera et al., 2004).  
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C). ECM-induced changes in overall chromatin structure may have profound implications 
on nuclear organization and gene expression 
ECM-induced foci formation may be explained also by the ability of lrECM to promote an 
overall decrease in total histone acetylation levels.  In proliferating monkey CV-1 cells, the 
formation of a nuclear body containing class I and II histone deacetylases, as well as SMRT and 
NCoR nuclear receptor corepressors were dependent on histone deacetylase activity (Downes et 
al., 2000). The integrity of these domains was disrupted by treatment with histone deacetylase 
inhibitors, substantiating again that the act of histone deacetylation plays an important role in 
nuclear organization. A function for DNA-mediated organization of nuclear factors is supported 
also by the findings of Kaminker and colleagues (2005) which showed that lrECM-induced 
cessation of growth in epithelial breast cell lines led to the formation of TIN2 foci. However, 
whereas treatment with DNase I eliminated the foci, treatment with RNase did not. One possible 
explanation for histone deacetylase-mediated formation of nuclear domains could be that histone 
deacetylation promotes the formation of highly condensed chromatin structures that would 
restrict the access of transcription factors to their target DNA sequences, thereby causing them to 
either localize to more accessible regions of the nucleus or amalgamate with nearby domains 
enriched in transcription factors. Such an event would also promote HERD formation since it 
would contribute to a decrease in transcription and RNA synthesis. 
VI. Advancing Towards a Deeper Understanding of the Malignant Phenotype 
Based on the discussion presented so far, our understanding of the effects of ECM on cellular, 
and, in particular, nuclear events important for normal cell differentiation is in its infancy. 
Furthermore, much remains to be learned of the effect of ECM on tumor cell development. We 
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have shown previously that non-malignant S1 and malignant T4-2 mammary epithelial cells 
express similar levels of β1-integrin and the coxsackievirus and adenovirus receptor (CAR) 
when cultured on a 2D plastic surface (Anders et al., 2003; Weaver et al., 1997) (see Table 2). 
However, when cultured in 3D lrECM, the expression levels of these receptors decline 
dramatically in non-malignant cells, but remain unaltered in malignant cells (Anders et al., 2003; 
Weaver et al., 1997). In addition, unlike S1 cells, T4-2 cells cultured on lrECM express a profile 
of cell surface receptors that favors increased proliferation through pathways involving the 
epidermal growth factor receptor (EGFR) and phosphatidylinositol 3-kinase  (PI3K) (Liu et al., 
2004; Wang et al., 1998; Weaver et al., 1997).  
Interestingly, the levels of β1-integrin, CAR, phosphorylated Akt and EGFR dramatically 
decline in T4-2 cells when cultured on 3D lrECM in the presence of a reverting agent that 
promotes the assembly of these cells into organized, polar structures closely resembling those 
that formed by non-malignant cells (Anders et al., 2003; Liu et al., 2004; Wang et al., 1998; 
Weaver et al., 1997). In addition, exposure to reverting agents induces T4-2 cells to express the 
tumor suppressor protein, anti-zuai-1 (AZU-1), to levels observed in S1 cells when cultured on 
either 2D plastic or 3D lrECM (Chen et al., 2000). In a recent study,  lrECM-induced 
morphogenesis of normal breast epithelial cells was shown to cause a drastic change in NuMA 
nuclear organization without inducing morphogenesis or changes in the distribution of NuMA in 
malignant cells (Knowles et al., 2006; Weaver et al., 1997). Thus, the nature with which a non-
malignant cell communicates with its 3D environment at both the cell surface and the nucleus 
differs from that of a malignant cell.  
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The ability of reverting agents to reverse the expression of T4-2 cell surface receptors and 
signaling proteins shows that the acquisition of a malignant phenotype is accompanied by 
changes in tissue architecture and reversible changes in protein expression that allow a 
transformed cell to bypass the strict hierarchical events inherent to normal cell differentiation. 
With this said, additional studies on normal and malignant mammary epithelial cells need to be 
performed to further understand and identify the cellular and nuclear events that allow a cancer 
cell to flourish uncontrollably in an environment that promotes the differentiation and growth 
cessation of normal cells.  
VII. A 3D Reconstruction for the Future of Cancer Research 
The union between a cell and its surrounding environment has profound implications on cellular 
processes such as proliferation, differentiation and apoptosis. However, during tumorigenesis, 
the communication between a cancer cell and its environment becomes altered. Mechanisms 
once enacted to provoke controlled growth and tissue-specific gene expression become obsolete, 
conferring a tumor cell with a growth advantage non-existent to a normal cell. While efforts have 
been made to elucidate the mechanisms through which ECM influences normal and tumor cell 
behavior and development, the underlying complexity with which a cell communicates with its 
external environment has thwarted advancements towards obtaining a deeper and truer 
understanding.  
The fact that only a handful of studies have looked at the relationship between ECM and the 
nucleus is surprising since it is now accepted that ECM signals to gene expression and almost 
every cellular component outside of the nucleus is affected by ECM. One can only imagine what 
intriguing discoveries remain to be uncovered in the nucleus by future investigations! Such 
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efforts will not only provide valuable basic information about signaling regulation but also may 
lead to identification of novel targets for drug therapy. 
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Figure 1. A schematic diagram illus trating the basic principles of dynamic reciprocity between 
neighboring cells and their extracellular environment. Mechanical and biochemical 
signals received at points of cell-cell or cell-ECM contact are transduced to the nucleus 
by transmembrane receptors, signaling molecules and cytoskeletal components where 
they initiate nuclear events resulting in the expression of specific gene products that are 
excreted back into the extracellular milieu. Green arrows represent the bidirectional flow 
of mechanical and biochemical signals between the ECM and the nucleus. RTKs 
represents receptor tyrosine kinase. (Modified, with permission, from Bissell et al., 
2005). 
 
Figure 2. An illustration of the different levels through which ECM controls gene expression and 
tissue function. As cells transition from a 2D monolayer to a 3D environment, they 
undergo changes in cell shape that influence the expression of certain genes. Exposure to 
ECM engages specific cell surface receptors and initiates the transduction of biochemical 
and mechanical signals through the cell to the nucleus, where they further influence gene 
expression. As the duration of exposure time to ECM increases, cells undergo 
morphogenic events involving the formation of acinar structures and once again exhibit 
changes in their gene expression profile. Thus, tissue structure influences gene expression 
and, therefore, dictates tissue function. (Modified, with permission, from Bissell et al., 
2005; Bissell et al., 1999; Roskelley et al., 1995). 
 
Figure 3. Schematic representation of lrECM- and prolactin-induced changes in nuclear 
organization and transcription factor binding in mammary epithelial cells that lead to the 
 34
initiation of β-casein gene transcription. In the absence of prolactin and lrECM, STAT5 
is predominantly cytoplasmic in primary cells. Exposure to lrECM and prolactin induces 
STAT5 phosphorylation, nuclear translocation and binding to its cognate DNA sequence 
in the β-casein promoter. In addition, this treatment increases the association of 
acetylated histones and promotes the binding of additional transcription factors including 
C/EBPβ, SWI/SNF, GR and RNA polymerase II to the β-casein promoter. Ac represents 
acetylation at lysine residues along histone N terminal tails. 
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